September 13th 2023
"Our study is the first report of bladder auto-transplantation in heart-beating, brain-dead human research donors as a necessary preparatory step toward clinical bladder transplantation in living patients," says Inderbir S. Gill, MD.
Expert Perspectives on Emerging CDK4/6 Inhibitor Strategies in Advanced Prostate Cancer Management Settings
View More
New York GU 17th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
March 8-9, 2024
Register Now!
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
How the Experts Treat NMIBC During a BCG Shortage—Integrating Recent Approvals and Investigational Therapies
View More
Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies
View More
Everything You Need to Know About PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?
View More
Clinical Case Vignette Series: Integrating Recent Data into Practice to Improve Outcomes in Advanced Prostate Cancer
View More
Medical Crossfire®: How Will Emerging Data Inform Treatment Planning for Patients With Prostate Cancer in the Community?
View More
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
[Quiz] Abdominal pain after laparoscopic nephrectomy
December 15th 2017A 46-year-old male underwent a left laparoscopic radical nephrectomy for a cT1b renal cell carcinoma. Intra-operatively, a rent in the descending mesocolon was made during bowel mobilization but was not closed. Subsequently, the patient presented to the emergency room 4 days later with complaints of sudden onset sharp abdominal pain and nausea. A non-contrast computed tomography scan was obtained. What is the diagnosis?
Bipolar TURP associated with ‘substantial’ cost savings
December 15th 2017Bipolar transurethral resection of the prostate offers an economic benefit compared with monopolar TURP that follows from the clinical differences between the two procedures, concluded investigators who presented their findings at the 2017 Western Section of the AUA annual meeting in Vancouver, BC.
PFUI treatment has benefits despite low initial success
December 1st 2017Early endoscopic realignment of pelvic fracture urethral injuries is associated with a low initial success rate, but the procedure does not hinder the success of subsequent urethroplasty and has other merits that may make it worthwhile, according to urologists from the University of Washington, Seattle.
Pediatrics: Less than half of undervirilized males receive molecular Dx
July 10th 2017The finding that the glans is a significant variable in hypospadias complications and an evaluation of external pelvic fixation alone without osteotomy at time of newborn bladder exstrophy closure were among the noteworthy studies in pediatric urology at AUA 2017.
Uro Pipeline: Phase IIb study begins for intraprostatic localized PCa drug
June 27th 2017Other pipeline developments include a new company formed to develop OAB treatments, a phase III urothelial cancer study meeting its primary endpoint, the formation of a partnership to study RCC treatment, and more.
Transgender surgery: Videos demonstrate cutting-edge techniques
In these videos, expert surgeons demonstrate robot-assisted penile inversion vaginoplasty, single-stage metoidioplasty, and simple orchiectomy for transgender patients.
Same-day outpatient anterior urethroplasty feasible
March 22nd 2017Single-stage anterior urethroplasty is feasible and safe when performed as a same-day outpatient procedure, even for men requiring combined substitution repairs, said University of Pittsburgh Medical Center urologists at the 2016 AUA annual meeting in San Diego.
Uro Pipeline: FDA accepts biologics license application for bladder Ca agent
January 13th 2017Other pipeline developments discussed include an implantable device for OAB treatment, a subcutaneous hypogonadism treatment, efficacy results for an HPV drug, and the status of a device-based BPH treatment.